Pharmaceutical

MiNA and Nippon Shinyaku enter RNAa therapeutics deal

MiNA Therapeutics has entered into an agreement with Nippon Shinyaku to develop RNAa therapeutics for rare neurodegenerative ailments.

Apr 7, 2024 - 00:00
MiNA and Nippon Shinyaku enter RNAa therapeutics deal
MiNA Therapeutics has entered into an agreement with Nippon Shinyaku to develop RNAa therapeutics for rare neurodegenerative ailments.
Read the original article

Tags:

Previous Article

Acumen and Lonza to produce Alzheimer’s drug sabirnetug

Next Article

Caris and Merck KGaA link to develop ADCs for cancer treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Ginkgo Bioworks and Merck partner to bolster biologic manufacturing

Ginkgo Bioworks and Merck partner to bolster biologic m...

Aug 8, 2023

Group behind ProMED fires three top moderators amid strike

Group behind ProMED fires three top moderators amid strike

Sep 8, 2023

STAT+: Relay’s breast cancer drug proves tolerable, but market is unimpressed

STAT+: Relay’s breast cancer drug proves tolerable, but...

Apr 19, 2023